Pulse Biosciences Inc.

NASDAQ: PLSE · Real-Time Price · USD
16.13
-1.18 (-6.82%)
At close: Aug 15, 2025, 2:57 PM

Pulse Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
106.35M 119.28M 118.04M 79.03M 26.2M 34.88M 44.37M 50.39M 58.75M 54.1M 61.14M 69.16M 14.8M 12.68M 28.61M 41.99M 47.43M 59.88M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a 1.89M n/a n/a n/a -2.73M n/a n/a n/a -3.25M n/a n/a n/a
Other Long-Term Assets
677K 678K 677K 646K 714K 365K -1.52M 365K 365K 365K 365K 365K 365K 365K -2.89M 365K 365K 365K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5K 8K 21K 61K 72K 8.37M -958K
Inventory
51K 30K n/a n/a n/a n/a n/a n/a n/a n/a n/a 750K 7.87M 7.49M 5.82M 4.28M 2.69M 1.14M
Other Current Assets
1.76M 1.6M 1.41M 1.38M 1.04M 964K 963K 1.24M 1.21M 849K 1.01M 1.24M 1.06M 1.98M 2.13M 2.87M n/a 958K
Total Current Assets
108.16M 120.91M 119.45M 80.41M 27.24M 35.85M 45.33M 51.62M 59.96M 54.95M 62.15M 71.16M 23.74M 22.16M 36.63M 49.21M 61.76M 61.98M
Property-Plant & Equipment
7.72M 7.95M 8.32M 7.81M 8.13M 8.44M 8.78M 9.11M 9.43M 9.73M 10.02M 10.54M 10.82M 11.16M 11.25M 11.4M 11.58M 11.71M
Goodwill & Intangibles
3.7M 3.85M 4.01M 4.18M 4.34M 4.51M 4.68M 4.84M 5.01M 5.17M 5.34M 5.51M 5.67M 5.84M 6.01M 6.17M 6.34M 6.51M
Total Long-Term Assets
12.09M 12.47M 13.01M 12.63M 13.19M 13.31M 15.48M 14.32M 14.8M 15.27M 15.73M 16.41M 16.86M 17.37M 17.62M 17.94M 18.28M 18.58M
Total Assets
120.25M 133.38M 132.46M 93.05M 40.43M 49.16M 60.8M 65.94M 74.76M 70.22M 77.88M 87.57M 40.6M 39.53M 54.25M 67.15M 80.04M 80.56M
Account Payables
2.74M 2.37M 1.67M 1.73M 1.64M 1.71M 1.84M 1.41M 1.79M 2.16M 1.57M 2.02M 1.95M 3.49M 2.9M 2.71M 2.82M 2.16M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K n/a 38K 32K 16K 16K 7K n/a n/a
Short-Term Debt
1.46M n/a n/a n/a n/a 1.1M 1.06M 1.02M 975K 801K 917K 98K 827K 799K 436K 1.09M 1.73M 118K
Other Current Liabilities
7.52M 2.68M 1.2M 3.11M 2.68M -1.1M 2.14M 1.24M 1.15M 1.48M 50K 1.15M 2.99M 2.89M 1.46M 1.42M 563K 2.19M
Total Current Liabilities
8.98M 7.76M 10.05M 6.74M 5.96M 5.08M 6.71M 5.43M 5.61M 6.99M 5.98M 7M 7.56M 8.9M 8.52M 9.52M 9.84M 8.53M
Long-Term Debt
6.79M n/a n/a n/a n/a n/a n/a n/a n/a 65M 65M 65M n/a n/a n/a n/a n/a 41M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
6.79M 7.17M 7.54M 7.17M 7.5M 7.8M 8.09M 8.37M 8.64M 73.9M 74.14M 74.38M 9.62M 9.83M 10.04M 10.24M 10.45M 51.63M
Total Liabilities
15.76M 14.93M 17.6M 13.91M 13.46M 12.88M 16.44M 13.8M 14.26M 80.89M 80.13M 81.38M 17.18M 18.74M 18.56M 19.76M 20.29M 60.16M
Total Debt
8.24M 8.58M 8.9M 8.37M 8.64M 8.9M 9.14M 9.38M 9.62M 75.63M 75.96M 75.34M 10.45M 10.63M 11.25M 12.08M 12.89M 52.38M
Common Stock
67K 67K 66K 62K 55K 55K 55K 55K 55K 37K 37K 37K 37K 29K 29K 29K 29K 26K
Retained Earnings
-426.46M -407.3M -390.5M -371.12M -358.44M -347.05M -336.92M -324.98M -314.42M -304.51M -294.7M -285.51M -267.47M -253.47M -236.2M -220.78M -206.5M -191.18M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -0.00 -0.00 n/a n/a n/a n/a n/a n/a
Shareholders Equity
104.49M 118.45M 114.86M 79.13M 26.97M 36.29M 44.36M 52.15M 60.5M -10.67M -2.25M 6.19M 23.41M 20.8M 35.69M 47.39M 59.75M 20.4M
Total Investments
n/a n/a n/a n/a n/a n/a 1.89M n/a n/a n/a -2.73M n/a n/a n/a n/a n/a n/a n/a